Day one ready
FY1 · Prescribing
Drug-chart review, dose calculations and ADR detection
Reading a chart critically rather than continuing it: what should stop, what is missing, what is causing the new problem.
Why this matters on day one
The commonest useful thing you can do on a ward round is notice that a drug is causing the symptom being investigated. Nobody else on the team is looking at the chart line by line, and the PSA tests exactly this.
The sequence
- 1Read it systematically. Allergies first. Then regular, then once-only, then as-required, then infusions, then the anticoagulant and insulin charts, which live separately and get forgotten.
- 2Ask of every drug. Is there still an indication? Is the dose right for this renal function and weight? Is it duplicated (two NSAIDs, two sedatives, a beta-blocker plus a rate-limiting calcium-channel blocker)? Is there an interaction? Does it need monitoring, and has that been done?
- 3Ask what is missing. VTE prophylaxis, aperients with opioids, gastroprotection with steroids or NSAIDs in the at-risk, bone protection with long-term steroids, and the time-critical drugs the patient takes at home.
- 4Suspect an ADR. Any new symptom after a new drug. Confusion after anticholinergics or opioids. AKI after an ACE inhibitor, NSAID or diuretic. Hyponatraemia after a thiazide or SSRI. Falls after antihypertensives or sedatives. Bradycardia after a beta-blocker or digoxin. Rash after an antibiotic.
- 5Act and report. Stop or change the drug, document your reasoning, tell the patient, and report a suspected adverse reaction through the Yellow Card scheme. Reporting is part of the job, not an optional extra.
What goes wrong
- Investigating a symptom thoroughly while its cause sits on the drug chart.
- Continuing a chart on admission without asking whether every drug is still appropriate for an acutely unwell inpatient.
- Forgetting the anticholinergic burden in the frail — it accumulates across several innocuous-looking drugs.
- Doing a calculation in your head. Write it down, and have it checked when it matters.
Escalate when
- Suspected serious ADR — anaphylaxis, Stevens–Johnson, agranulocytosis, serotonin syndrome, NMS.
- Any error that has reached the patient → tell a senior, tell the patient, and complete an incident report.
- Complex polypharmacy in the frail → pharmacist-led structured medication review.
BNF · MHRA Yellow Card scheme · STOPP/START criteria